A detailed history of Jump Financial, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 36,994 shares of ABBV stock, worth $7.21 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
36,994
Previous 17,009 117.5%
Holding current value
$7.21 Million
Previous $3.1 Million 104.88%
% of portfolio
0.13%
Previous 0.09%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $3.09 Million - $3.61 Million
19,985 Added 117.5%
36,994 $6.35 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $1.73 Million - $1.97 Million
10,839 Added 175.67%
17,009 $3.1 Million
Q4 2023

Feb 07, 2024

SELL
$137.6 - $154.97 $5.93 Million - $6.68 Million
-43,122 Reduced 87.48%
6,170 $956,000
Q3 2023

Nov 07, 2023

SELL
$133.59 - $154.65 $997,917 - $1.16 Million
-7,470 Reduced 13.16%
49,292 $7.35 Million
Q2 2023

Aug 07, 2023

BUY
$132.51 - $164.9 $7.52 Million - $9.36 Million
56,762 New
56,762 $7.65 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $258,224 - $309,679
-1,867 Reduced 45.32%
2,253 $364,000
Q3 2022

Nov 07, 2022

BUY
$134.21 - $153.93 $552,945 - $634,191
4,120 New
4,120 $553,000
Q4 2021

Feb 10, 2022

SELL
$107.43 - $135.93 $2.14 Million - $2.71 Million
-19,923 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $1.82 Million - $2.07 Million
17,119 Added 610.52%
19,923 $2.15 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $466,711 - $519,943
-4,436 Reduced 61.27%
2,804 $316,000
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $350,684 - $386,061
3,428 Added 89.93%
7,240 $783,000
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $306,827 - $414,250
3,812 New
3,812 $408,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.